RE: Question for those with experience.8 Dec 2023 10:58
Hold on a minute. Let’s just have a look at this ‘data won’t be a catalyst’ theme that’s playing out.
The data will underpin the degree of response a terminal patient has seen whilst on the drug. As in, a SIGNIFICANT response in quantifiable terms. Not just ‘remarkable’ from AS. A percentage reduction, aligned to RECIST.
To contextualise this, when we get this data, it’ll read across to other trials. And confirm we have succeeded where others have failed. VERY simple. And VERY valuable.
Now, tell me data won’t be a driver?
He’s either lying, ramping, or telling truth that adds meat to the unicorns bones.